TTG Imaging Solutions has acquired Nuclear Imaging Services, a provider of imaging equipment, parts and services, and its cardiac-based radiopharmacy, NISotopes.
The purchase of the Texas-based enterprises expands the TTG footprint throughout the country and broadens its base of healthcare providers, while forming one of the largest, independent, full-service diagnostic imaging equipment companies in the U.S.
“This merger/acquisition with TTG aligns our customer centric philosophy that NIS and NISotopes was based upon, bringing like-minded organizations together that focus on prioritizing its customers first,” NIS president and CEO Mike Hewitt said in a statement.
Previously known as TTG Healthcare, the company changed its name to TTG Imaging Solution
at the beginning of 2020 and merged TTG Diagnostic Solutions; Cardiologic, LLC; and Omni Diagnostics into Cardiac Imaging Solutions (CIS).
The agreement with Nuclear Imaging Services and NISotopes is expected to broaden TTG’s portfolio of clinical staff and radiopharmaceutical offerings. It increases the company’s industry experience beyond 100 years and equips it with more than 250 employees, including 40 OEM-certified field service engineers.
It also builds on TTG’s acquisition of Molecular Imaging Specialists, a medical imaging equipment and service provider based in Florida that builds on TTG’s presence in the market there and in the southeast region of the country, and provides it with a strong service and technical foundation in the field of nuclear medicine.
“We continue to add quality companies to our business platform such as MIS, but the acquisition of NIS is a transformational event in scale and expertise that will drive our company to new performance heights,” said TTG President and CEO Jack Tomayko in a statement.
No financial details were disclosed.